OPN-019
- Generic Name
- OPN-019
A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2022-05-02
- Lead Sponsor
- Optinose US Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT05035576
- Locations
- 🇲🇽
Fundacion Santos y de la Garza Evia, I.B.P, Monterrey, N.l., Mexico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath